Weston Family Foundation awards two McGill researchers combatting neurodegenerative diseases of aging
Etienne de Villers-Sidani and Philippe Huot have been awarded funding from the Weston Family Foundation’s Rapid Response program for their innovative research advancing diagnostic tools and interventions for Alzheimer's disease and Parkinson’s disease.
Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.
Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.
Three McGill researchers receive SSHRC Partnership Engage Grants
The Social Science and Humanities Research Council of Canada (SSHRC) announced recipients of the latest Partnership Engage Grants competition, including a total of $73,782 awarded to three McGill researchers
The 2026 Dr. Donald G. Doehring Memorial Lecture
Thursday March 12 2026 • 4:30pm to 6pm Dentistry Suite #102, 2001 Avenue McGill College
Anna Papafragou, PhD Professor • Department of Linguistics, University of Pennsylvania
New evidence challenges understanding of Parkinson’s disease
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson’s disease treatments.
Fine particles in pollution are associated with early signs of autoimmune disease
A new study has linked air pollution exposure and immune-system changes that often precede the onset of autoimmune diseases.
McGill University researchers analyzing Ontario data found that fine particles in air pollution are associated with higher levels of a biomarker linked with autoimmune diseases, such as systemic lupus.
Amazing Brain Science Talks 2025: Exploring Brain-Heart Connections
On Saturday, November 8, 2025, Healthy Brains, Healthy Lives (HBHL) presented the third edition of the Amazing Brain Science Talks, in partnership with Brain Canada Foundation and the Brain-Heart Interconnectome.
McGill moves up to third overall in Research Infosource rankings, maintains its No. 2 position for medical research
The University continues to be recognized as one of Canada’s top research institutions and drivers of innovation
Group therapy helps cancer survivors reclaim life after treatment
A program developed by a McGill researcher to help cancer survivors cope with the fear their cancer will return is expanding across Canada.
The Fear of Recurrence Therapy (FORT) program offers evidence-based support to address what co-founder Christine Maheu calls one of the most overlooked aspects of recovery.
McGill researchers awarded funding to strengthen national capacity in metaresearch
Sam Harper and Arijit Nandi have received funding to help strengthen national capacity in metaresearch through the Research-on-Research joint initiative, supported by the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR), and Michael Smith Health Research BC (MSHRBC).
24 McGill researchers identified in Clarivate Highly Cited Researchers List
Twenty-four McGill researchers have been named to the 2025 Highly Cited Researchers™ list, a ranking prepared each year by Clarivate, an analytics company based in the US. The list assesses researchers in a wide range of disciplines, from neuroscience to environmental science. The number of McGill scholars on the list grew from 14 in 2024 to 24 in 2025.
Cancer Research Society invests in McGill discoveries
Twenty-two McGill researchers have received funding from the Cancer Research Society (CRS) through its Operating Grants competition, announced on
New therapeutic strategies show promise against a hard-to-treat prostate cancer
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI) identified a mechanism driving neuroendocrine prostate cancer, a rare and highly aggressive subtype for which there currently are no effective treatment options.
Heavy cannabis use during pregnancy linked to disruption in brain growth
McGill University researchers at the Douglas Research Centre have found evidence that heavy cannabis use during pregnancy can cause delays in brain development in the fetus that persist into adulthood.
Using advanced MRI techniques, the team tracked the effects of prenatal cannabis exposure in mice across key developmental stages.
Lesser-known eating disorder just as severe as anorexia and bulimia, study finds
A diagnosis often viewed as less serious than anorexia and bulimia – and the most common eating disorder worldwide – can cause just as much harm, a new study has found.
